|
US5128326A
(en)
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
CA2071867A1
(en)
|
1989-11-06 |
1991-05-07 |
Edith Mathiowitz |
Method for producing protein microspheres
|
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US5804396A
(en)
|
1994-10-12 |
1998-09-08 |
Sugen, Inc. |
Assay for agents active in proliferative disorders
|
|
ATE446955T1
(de)
|
1995-03-30 |
2009-11-15 |
Pfizer Prod Inc |
Chinazolinone derivate
|
|
GB9508537D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
GB9508565D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quiazoline derivative
|
|
AU710347B2
(en)
|
1995-08-31 |
1999-09-16 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
|
CN100503580C
(zh)
|
1996-04-12 |
2009-06-24 |
沃尼尔·朗伯公司 |
酪氨酸激酶的不可逆抑制剂
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
ZA986732B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitiors of tyrosine kinases
|
|
ZA986729B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitors of tyrosine kinases
|
|
TW436485B
(en)
|
1997-08-01 |
2001-05-28 |
American Cyanamid Co |
Substituted quinazoline derivatives
|
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
|
AU2004257373B2
(en)
|
2003-07-16 |
2011-03-24 |
Arbutus Biopharma Corporation |
Lipid encapsulated interfering RNA
|
|
WO2006029161A2
(en)
|
2004-09-07 |
2006-03-16 |
The Board Of Regents For Oklahoma State University |
Cell specific gene silencing using cell-specific promoters in vitro and in vivo
|
|
EP2239328A3
(en)
|
2005-08-18 |
2011-01-05 |
Alnylam Pharmaceuticals Inc. |
Methods and compositions for treating neurological disease
|
|
AU2013203219B2
(en)
|
2005-11-02 |
2016-09-22 |
Arbutus Biopharma Corporation |
MODIFIED siRNA MOLECULES AND USES THEREOF
|
|
EP1948674A4
(en)
|
2005-11-02 |
2009-02-04 |
Protiva Biotherapeutics Inc |
MODIFIED SIRNA MOLECULES AND APPLICATIONS THEREOF
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
WO2007130604A2
(en)
|
2006-05-04 |
2007-11-15 |
Baylor Research Institute |
Anti-tumor activity of an oncolytic adenovirus-delivered oncogene sirna
|
|
US20080039415A1
(en)
|
2006-08-11 |
2008-02-14 |
Gregory Robert Stewart |
Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
|
|
US20100125919A1
(en)
|
2007-01-18 |
2010-05-20 |
Lionel Navarro |
Methods and compositions for modulating the mirna pathway
|
|
US8507455B2
(en)
|
2007-12-04 |
2013-08-13 |
Alnylam Pharmaceuticals, Inc. |
Folate conjugates
|
|
WO2009104051A2
(en)
|
2007-12-31 |
2009-08-27 |
Lu Patrick Y |
Combinational therapeutics for treatment of prostate cancer using epoxy encapsulated magnetic particles and rnai medicine
|
|
WO2009120878A2
(en)
|
2008-03-26 |
2009-10-01 |
Alnylam Pharmaceuticals, Inc. |
Non-natural ribonucleotides, and methods of use thereof
|
|
US8575123B2
(en)
|
2008-04-11 |
2013-11-05 |
Tekmira Pharmaceuticals Corporation |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
AU2009273878A1
(en)
|
2008-07-25 |
2010-01-28 |
Alnylam Pharmaceuticals, Inc. |
Enhancement of siRNA silencing activity using universal bases or mismatches in the sense strand
|
|
WO2010039548A2
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
|
WO2010078517A2
(en)
|
2008-12-31 |
2010-07-08 |
Sirnaomics, Inc. |
Compositions and methods using sirna molecules and sirna cocktails for the treatment of breast cancer
|
|
CA2760706C
(en)
|
2009-05-05 |
2019-08-06 |
Alnylam Pharmaceuticals, Inc. |
Methods of delivering oligonucleotides to immune cells
|
|
CN102753187A
(zh)
|
2009-06-03 |
2012-10-24 |
戴瑟纳制药公司 |
肽-dicer底物试剂及其特异性抑制基因表达的方法
|
|
WO2011008982A1
(en)
|
2009-07-15 |
2011-01-20 |
Sah Dinah W Y |
Treatment of neurological disorders
|
|
TW201124160A
(en)
|
2009-11-26 |
2011-07-16 |
Quark Pharmaceuticals Inc |
SiRNA compounds comprising terminal substitutions
|
|
SI2506857T1
(en)
|
2009-12-01 |
2018-08-31 |
Translate Bio, Inc. |
Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
|
|
CA3044884A1
(en)
|
2009-12-07 |
2011-06-16 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
|
WO2011072292A2
(en)
|
2009-12-11 |
2011-06-16 |
Dicerna Pharmaceuticals, Inc. |
Phase changing formulations of rna and rna derivatives
|
|
US20120315324A1
(en)
|
2010-02-05 |
2012-12-13 |
University Of Louisville Research Foundation, Inc. |
Exosomal compositions and methods for the treatment of disease
|
|
EP2560635A4
(en)
|
2010-04-23 |
2013-04-03 |
Kineta Inc |
ANTIVIRAL CONNECTIONS
|
|
US20130123338A1
(en)
|
2010-05-12 |
2013-05-16 |
Protiva Biotherapeutics, Inc. |
Novel cationic lipids and methods of use thereof
|
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
WO2013048734A1
(en)
|
2011-09-28 |
2013-04-04 |
Tufts Medical Center, Inc. |
Treatment and prevention of cardiovascular disease with cell derived lipid vesicles, microvesicles and exosomes
|
|
EP2725103A3
(en)
|
2011-11-14 |
2016-01-06 |
Silenseed Ltd |
Methods and compositions for treating prostate cancer
|
|
US20130178421A1
(en)
|
2012-01-06 |
2013-07-11 |
Alcon Research, Ltd. |
Interfering rna delivery system and uses thereof
|
|
US9352042B2
(en)
|
2012-02-24 |
2016-05-31 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
|
KR20150046259A
(ko)
|
2012-08-23 |
2015-04-29 |
앨리오스 바이오파마 인크. |
파라믹소바이러스 바이러스성 감염의 치료용 화합물
|
|
EA037503B1
(ru)
|
2014-01-21 |
2021-04-05 |
Анджариум Байосайенсиз Аг |
Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства
|
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
|
EP3212159A4
(en)
*
|
2014-10-29 |
2018-06-27 |
The Regents of the University of California |
Bioactive delivery vehicles
|
|
SG10202008883SA
(en)
*
|
2016-03-15 |
2020-10-29 |
Codiak Biosciences Inc |
Therapeutic membrane vesicles
|
|
GB201609216D0
(en)
|
2016-05-25 |
2016-07-06 |
Evox Therapeutics And Isis Innovation Ltd |
Exosomes comprising therapeutic polypeptides
|
|
GB2552301A
(en)
|
2016-07-11 |
2018-01-24 |
Evox Therapeutics Ltd |
Metabolic drug loading of EVs
|
|
GB2552460A
(en)
|
2016-07-11 |
2018-01-31 |
Evox Therapeutics Ltd |
CPP-Mediated EV Loading
|
|
US20180193270A1
(en)
|
2016-11-29 |
2018-07-12 |
PureTech Health LLC |
Exosomes for delivery of therapeutic agents
|
|
WO2019018349A1
(en)
|
2017-07-17 |
2019-01-24 |
Codiak Biosciences, Inc. |
NANOVESICLES PRODUCED FROM MESENCHYMAL STROMAL CELLS FOR ANTI-INFLAMMATORY APPLICATIONS
|
|
KR20240033086A
(ko)
|
2017-08-25 |
2024-03-12 |
코디악 바이오사이언시즈, 인크. |
막 단백질을 사용한 치료용 엑소좀의 제조
|
|
GB201717446D0
(en)
|
2017-10-24 |
2017-12-06 |
Evox Therapeutics Ltd |
Affinity purification of engineering extracellular vesicles
|
|
GB2568255A
(en)
|
2017-11-08 |
2019-05-15 |
Evox Therapeutics Ltd |
Exosomes comprising RNA therapeutics
|
|
GB201718681D0
(en)
|
2017-11-13 |
2017-12-27 |
Evox Therapeutics Ltd |
Protein engineered extracellular vesicles
|
|
US20190175506A1
(en)
|
2017-11-17 |
2019-06-13 |
Codiak Biosciences, Inc. |
Loading of Extracellular Vesicles through Imparting of Mechanical Shear
|
|
EP3731849A4
(en)
|
2017-12-28 |
2021-12-01 |
Codiak BioSciences, Inc. |
EXOSOME FOR IMMUNONCOLOGICAL AND ANTI-INFLAMMATORY THERAPY
|
|
GB201802163D0
(en)
|
2018-02-09 |
2018-03-28 |
Evox Therapeutics Ltd |
Compositions for EV storage and formulation
|
|
CA3098623A1
(en)
|
2018-05-07 |
2019-11-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
|
GB201809622D0
(en)
|
2018-06-12 |
2018-07-25 |
Evox Therapeutics Ltd |
Engineering extracellular vesicles for affinity purification
|
|
GB201810301D0
(en)
|
2018-06-22 |
2018-08-08 |
Evox Therapeutics Ltd |
Combinatorial gene therapy
|
|
CN112888305A
(zh)
|
2018-08-17 |
2021-06-01 |
国家科学研究中心 |
保护动物防御病原细菌和/或促进共生和共栖细菌的有益作用的基于rna的治疗方法
|
|
WO2020041720A1
(en)
|
2018-08-24 |
2020-02-27 |
Codiak Biosciences, Inc. |
Extracellular vesicles targeting dendritic cells and uses thereof
|
|
CN113286882A
(zh)
|
2018-11-09 |
2021-08-20 |
阿布特斯生物制药公司 |
脂质纳米颗粒制剂
|
|
CN113272426A
(zh)
|
2018-11-16 |
2021-08-17 |
医福斯治疗有限公司 |
用于尿素循环蛋白和核酸的替代的细胞外囊泡
|
|
JP7535047B2
(ja)
|
2018-12-12 |
2024-08-15 |
ディセルナ ファーマシューティカルズ インコーポレイテッド |
トリループを含む二本鎖核酸インヒビター分子
|
|
CN110699382A
(zh)
|
2019-11-08 |
2020-01-17 |
赵凯 |
一种递送siRNA的外泌体的制备方法
|
|
IT201900024580A1
(it)
*
|
2019-12-18 |
2021-06-18 |
Consiglio Nazionale Ricerche |
Vescicole extracellulari da microalghe
|
|
EP3967746A1
(en)
*
|
2020-09-11 |
2022-03-16 |
Immunrise |
Chlorella-based production of extracellular vesicle-embedded small rnas for prophylactic or therapeutic applications
|
|
EP3967745A1
(en)
*
|
2020-09-11 |
2022-03-16 |
Immunrise |
Chlorella-based production of extracellular vesicle-embedded small rnas for biocontrol applications
|